🟢 Neumora Therapeutics is trading 6.83% up today as biotech sector gains

Neumora Therapeutics is trading at $0.61, up 6.83%, with no confirmed company-specific announcement explaining the November 4 move.

• Neumora Therapeutics’ estimated earnings date is November 5; a direct connection to the move is unconfirmed.
• Biotech’s XBI sector trend is positive, up 2.13% during the regular session, providing sector context rather than a company-specific catalyst.
• Nasdaq reported premarket volume of 10,353 at 5:05 a.m. ET.